Site search
2860 results for '' found
A Phase 1b Open-label Study to Investigate the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults with Relapsed or Refractory B cell Precursor
A Phase 1b Open-label Study to Investigate the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Adults with Relapsed or Refractory B cell Precursor
/
A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT05936359)
A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms (NCT05936359)
/
https://app.prompt.org.au/download/253190?code=bf75f8cc-636e-4810-afcc-8ced5fffb360
Life in the Alfred ICU
Most people who pass by The Alfred’s ICU building are unaware of what happens inside – but anyone who has entered its doors as a staff member, a patient or a loved one, will have a compelling story to tell.
/news/the-many-faces-of-the-alfreds-icu
World-first trial takes aim at deadly silicosis
New hope is on the horizon for silicosis sufferers with Melbourne experts set to embark on a world-first trial designed to halt progression of the deadly lung disease.
/news/world-first-trial-takes-aim-at-deadly-silicosis
Alfred_Health_GP_News_-_August_2025.pdf
Vic’s road to transplant
As 54 year old Vic Wiggins waited for a lifesaving heart transplant, he never gave up hope he’d one day be able to join his son on a long bike ride.
/news/vics-road-to-transplant
Ryan Smith
/about/bio/ryan-smith
Kathy Lo
Kathy began her professional career in Perth where she spent several years as a clinical nurse in neurology and some time as an acting clinical nurse specialist in stroke. She then moved to Melbourne where she worked on the infectious diseases ward during covid, as well as the haematology ward…
/about/bio/kathy-lo